Hennepin Healthcare

hennepinhealthcare.org

Hennepin Healthcare is an integrated system of care that includes HCMC, a nationally recognized Level I Adult Trauma Center and Level I Pediatric Trauma Center and acute care hospital, as well as a clinic system with primary care clinics located in Minneapolis and across Hennepin County. The comprehensive healthcare system includes a 484-bed academic medical center, a large outpatient Clinic & Specialty Center, and a network of clinics downtown and in the North Loop, Whittier, and East Lake Street neighborhoods of Minneapolis, and in the suburban communities of Brooklyn Park, Golden Valley.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMA TECH

XTALPI PARTNERS WITH SINGAPORE'S DRUG DISCOVERY PLATFORM TO FIND BETTER CANCER TREATMENTS

XtalPi Inc. | December 29, 2022

news image

One of the pioneering pharmaceutical technology companies - XtalPi, powered by artificial intelligence (AI) and automation, has recently announced a strategic collaboration with Singapore's national platform for drug discovery and development, the Experimental Drug Development Centre (EDDC), which is hosted by the Agency for Science, Technology, and Research of Singapore (A*STAR). The goal of this partnership is to find novel treatment candidates for non-small cell lung cancer (NSCLC)....

Read More

Pharmacy Market

CASCADE CHEMISTRY INITIATES $14 MILLION EXPANSION OF CGMP PHARMACEUTICAL MANUFACTURING CAPACITY

Cascade Chemistry | February 19, 2021

news image

Cascade Chemistry, a main pharmaceutical contract development and manufacturing organization, today declared inception of development of new offices intended to expand the organization's ability to manufacture APIs (dynamic pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures). The new offices, expected to be operational in the main quarter of 2022, will eventually expand the organization's floor space just about three-overl...

Read More

Pharma Tech

DOUGLAS PHARMACEUTICALS FORMS LEAD PROGRAM R-107 CLINICAL ADVISORY BOARD

Douglas Pharmaceuticals | January 27, 2023

news image

A clinical advisory board has been established to support Douglas Pharmaceuticals' lead program R-107, an oral extended-release dose of racemic ketamine being developed as an adjunctive or stand-alone therapy for treatment-resistant depression. Douglas Pharmaceuticals is a New Zealand-based pharmaceutical company specializing in the development of specialty generic and repurposed medications (TRD). Peter Surman, Chief Scientific Officer expressed, "We are ver...

Read More

Pharma Tech

PATHAI ANNOUNCES STRATEGIC PARTNERSHIP WITH ROCHE TO ENABLE DEVELOPMENT AND DISTRIBUTION OF DIGITAL PATHOLOGY DIAGNOSTICS

Roche | October 15, 2021

news image

PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Roche, a global pioneer in pharmaceuticals and diagnostics, announced a strategic partnership to develop and distribute PathAI's AI-powered technology through Roche's uPath enterprise software, enabling broad access to digital pathology diagnostics to support clinical research and companion diagnostic (CDx) programs globally. AI-powered pathology has the potential to inform biomar...

Read More
news image

Business Insights, PHARMA TECH

XTALPI PARTNERS WITH SINGAPORE'S DRUG DISCOVERY PLATFORM TO FIND BETTER CANCER TREATMENTS

XtalPi Inc. | December 29, 2022

One of the pioneering pharmaceutical technology companies - XtalPi, powered by artificial intelligence (AI) and automation, has recently announced a strategic collaboration with Singapore's national platform for drug discovery and development, the Experimental Drug Development Centre (EDDC), which is hosted by the Agency for Science, Technology, and Research of Singapore (A*STAR). The goal of this partnership is to find novel treatment candidates for non-small cell lung cancer (NSCLC)....

Read More
news image

Pharmacy Market

CASCADE CHEMISTRY INITIATES $14 MILLION EXPANSION OF CGMP PHARMACEUTICAL MANUFACTURING CAPACITY

Cascade Chemistry | February 19, 2021

Cascade Chemistry, a main pharmaceutical contract development and manufacturing organization, today declared inception of development of new offices intended to expand the organization's ability to manufacture APIs (dynamic pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures). The new offices, expected to be operational in the main quarter of 2022, will eventually expand the organization's floor space just about three-overl...

Read More
news image

Pharma Tech

DOUGLAS PHARMACEUTICALS FORMS LEAD PROGRAM R-107 CLINICAL ADVISORY BOARD

Douglas Pharmaceuticals | January 27, 2023

A clinical advisory board has been established to support Douglas Pharmaceuticals' lead program R-107, an oral extended-release dose of racemic ketamine being developed as an adjunctive or stand-alone therapy for treatment-resistant depression. Douglas Pharmaceuticals is a New Zealand-based pharmaceutical company specializing in the development of specialty generic and repurposed medications (TRD). Peter Surman, Chief Scientific Officer expressed, "We are ver...

Read More
news image

Pharma Tech

PATHAI ANNOUNCES STRATEGIC PARTNERSHIP WITH ROCHE TO ENABLE DEVELOPMENT AND DISTRIBUTION OF DIGITAL PATHOLOGY DIAGNOSTICS

Roche | October 15, 2021

PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Roche, a global pioneer in pharmaceuticals and diagnostics, announced a strategic partnership to develop and distribute PathAI's AI-powered technology through Roche's uPath enterprise software, enabling broad access to digital pathology diagnostics to support clinical research and companion diagnostic (CDx) programs globally. AI-powered pathology has the potential to inform biomar...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us